| Gene Symbol | HIP1 |
| Entrez ID | 3092 |
| Uniprot ID | O00291 |
| Description | huntingtin interacting protein 1 |
| Chromosomal Location | chr7: 75,533,300-75,738,962 |
| Ontology | GO ID | GO Term | Definition | Evidence |
|---|---|---|---|---|
|
BP |
GO:0006351 |
transcription, DNA-templated |
The cellular synthesis of RNA on a template of DNA. |
IEA |
|
BP |
GO:0006355 |
regulation of transcription, DNA-templated |
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
IEA |
|
BP |
GO:0006915 |
apoptotic process |
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
IDA |
|
BP |
GO:0006919 |
activation of cysteine-type endopeptidase activity involved in apoptotic process |
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process. |
IDA |
|
BP |
GO:0007010 |
cytoskeleton organization |
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures. |
IEA |
|
BP |
GO:0030154 |
cell differentiation |
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
IEA |
|
BP |
GO:0042981 |
regulation of apoptotic process |
Any process that modulates the occurrence or rate of cell death by apoptotic process. |
IDA |
|
BP |
GO:0048260 |
positive regulation of receptor-mediated endocytosis |
Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport. |
IMP |
|
BP |
GO:0048268 |
clathrin coat assembly |
The process that results in the assembly of clathrin triskelia into the ordered structure known as a clathrin cage. |
IDA |
|
BP |
GO:0072583 |
clathrin-dependent endocytosis |
An endocytosis process that begins when material is taken up into clathrin-coated pits, which then pinch off to form clathrin-coated endocytic vesicles. |
IEA |
|
BP |
GO:0097190 |
apoptotic signaling pathway |
A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered. |
IDA |
|
CC |
GO:0005634 |
nucleus |
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
IEA |
|
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA |
|
CC |
GO:0005794 |
Golgi apparatus |
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions. |
IDA |
|
CC |
GO:0005856 |
cytoskeleton |
Any of the various filamentous elements that form the internal framework of cells, and typically remain after treatment of the cells with mild detergent to remove membrane constituents and soluble components of the cytoplasm. The term embraces intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. |
TAS |
|
CC |
GO:0016020 |
membrane |
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
TAS |
|
CC |
GO:0030136 |
clathrin-coated vesicle |
A vesicle with a coat formed of clathrin connected to the membrane via one of the clathrin adaptor complexes. |
IDA |
|
CC |
GO:0030665 |
clathrin-coated vesicle membrane |
The lipid bilayer surrounding a clathrin-coated vesicle. |
IEA |
|
CC |
GO:0043231 |
intracellular membrane-bounded organelle |
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane. |
IDA |
|
MF |
GO:0003779 |
actin binding |
Interacting selectively and non-covalently with monomeric or multimeric forms of actin, including actin filaments. |
IEA |
|
MF |
GO:0005200 |
structural constituent of cytoskeleton |
The action of a molecule that contributes to the structural integrity of a cytoskeletal structure. |
TAS |
|
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
|
MF |
GO:0030276 |
clathrin binding |
Interacting selectively and non-covalently with a clathrin heavy or light chain, the main components of the coat of coated vesicles and coated pits, and which also occurs in synaptic vesicles. |
IDA |
|
MF |
GO:0035091 |
phosphatidylinositol binding |
Interacting selectively and non-covalently with any inositol-containing glycerophospholipid, i.e. phosphatidylinositol (PtdIns) and its phosphorylated derivatives. |
IDA |
| Domain ID | Description |
|---|---|
|
IPR002558 |
I/LWEQ domain |
|
IPR008942 |
ENTH/VHS |
|
IPR011417 |
AP180 N-terminal homology (ANTH) domain |
|
IPR013809 |
ENTH domain |
|
IPR030224 |
Sla2 family |
|
IPR030554 |
Huntingtin-interacting protein 1 |
|
IPR032422 |
Huntingtin-interacting protein 1, clathrin-binding domain |
| Pathway ID | Pathway Term | Pathway Source |
|---|---|---|
|
hsa05016 |
Huntington's disease |
KEGG |
| UMLS CUI | UMLS Term |
|---|---|
|
C0024141 |
Lupus Erythematosus, Systemic |
|
C0033578 |
Prostatic Neoplasms |
| Tissue | Cell Type |
|---|---|
|
caudate |
glial cells |
|
cerebral cortex |
endothelial cells |
|
cerebral cortex |
glial cells |
|
cerebral cortex |
neuropil |
|
colon |
endothelial cells |
|
colon |
peripheral nerve/ganglion |
|
endometrium |
glandular cells |
|
epididymis |
glandular cells |
|
fallopian tube |
glandular cells |
|
kidney |
cells in glomeruli |
|
kidney |
cells in tubules |
|
lung |
pneumocytes |
| Pubmed ID | Author | Year | Title |
|---|---|---|---|
|
12734205 |
Wood et al. |
2003 |
The Molecular Phenotype of Polycystic Ovary Syndrome (PCOS) Theca Cells and New Candidate PCOS Genes Defined by Microarray Analysis |
|
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
| Gene Symbol | Entrez ID | Uniprot ID | Score |
|---|---|---|---|
|
UBA1 |
7317 |
P22314 |
0.49 |
|
UBE2N |
7334 |
P61088 |
0.49 |
|
UBE2V1 |
387522 |
Q13404 |
0.49 |
|
CASP3 |
836 |
P42574 |
0.52 |
|
TFAP2A |
7020 |
P05549 |
0.55 |
|
CASP9 |
842 |
P55211 |
0.59 |
|
CLTA |
1211 |
P09496 |
0.59 |
|
APAF1 |
317 |
O14727 |
0.62 |
|
AP2B1 |
163 |
P63010 |
0.63 |
|
EIF6 |
3692 |
P56537 |
0.63 |
|
PFDN1 |
5201 |
O60925 |
0.63 |
|
REL |
5966 |
Q04864 |
0.63 |
|
RPS10 |
6204 |
P46783 |
0.63 |
|
DAZAP2 |
9802 |
Q15038 |
0.63 |
|
BFAR |
51283 |
Q9NZS9 |
0.63 |
|
HIP1 |
3092 |
O00291 |
0.78 |
|
AP2A1 |
160 |
O95782 |
0.80 |
|
CLTCL1 |
8218 |
P53675 |
0.80 |
|
CLTB |
1212 |
P09497 |
0.82 |
|
HTT |
3064 |
P42858 |
0.90 |
|
CLTC |
1213 |
Q00610 |
0.97 |
|
TMEM17 |
200728 |
Q86X19 |
0.49 |
|
MAP3K1 |
4214 |
Q13233 |
0.52 |
|
FBXO25 |
26260 |
Q8TCJ0 |
0.52 |
|
NTRK1 |
4914 |
P04629 |
0.63 |
|
MAPK6 |
5597 |
Q16659 |
0.63 |
|
ITSN1 |
6453 |
Q15811 |
0.63 |
|
VCAM1 |
7412 |
P19320 |
0.63 |
|
ITGB3BP |
23421 |
Q13352 |
0.63 |
|
CCDC67 |
159989 |
Q05D60 |
0.63 |
|
GAK |
2580 |
O14976 |
0.72 |
|
MYH9 |
4627 |
P35579 |
0.72 |
|
GTSE1 |
51512 |
Q9NYZ3 |
0.72 |
|
CASP8 |
841 |
Q14790 |
0.73 |
|
IFT57 |
55081 |
Q9NWB7 |
0.77 |
|
HIP1R |
9026 |
O75146 |
0.89 |